Literature DB >> 32694617

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

Sylvie Tondeur1,2, Franciane Paul3, Jérémie Riou4, Olivier Mansier5, Dana Ranta6, Lenaïg Le Clech7, Eric Lippert8,9,10, Suzanne Tavitian11, Driss Chaoui12, Mélanie Mercier13, Benoit De Renzis14, Laurane Cottin9,15,16,17, Bruno Cassinat18, Jean-Marie Chrétien19, Jean-Christophe Ianotto9,20, Olivier Allangba21, Christophe Marzac22, Laurent Voillat23, Françoise Boyer9,24, Corentin Orvain9,24, Mathilde Hunault-Berger9,16,17,24, François Girodon25, Jean-Jacques Kiladjian26, Valérie Ugo9,15,16,17, Damien Luque Paz27,28,29,30.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32694617     DOI： 10.1038/s41375-020-0991-x

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.

Authors:  Yoko Edahiro; Tomoki Ito; Akihiko Gotoh; Mika Nakamae; Fumihiko Kimura; Michiaki Koike; Keita Kirito; Hideho Wada; Kensuke Usuki; Takayuki Tanaka; Takehiko Mori; Satoshi Wakita; Toshiki I Saito; Akiko Kada; Akiko M Saito; Kazuya Shimoda; Yuka Sugimoto; Toshiro Kurokawa; Akihiro Tomita; Yoshinori Hashimoto; Koichi Akashi; Itaru Matsumura; Katsuto Takenaka; Norio Komatsu
Journal:  Int J Hematol       Date:  2022-07-09       Impact factor: 2.319

2.  JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.

Authors:  Zuzanna Kanduła; Michał Janowski; Barbara Więckowska; Edyta Paczkowska; Krzysztof Lewandowski
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-15       Impact factor: 4.322

Review 3.  Genetic Background of Polycythemia Vera.

Authors:  Mathilde Regimbeau; Romain Mary; François Hermetet; François Girodon
Journal:  Genes (Basel)       Date:  2022-04-02       Impact factor: 4.141

Review 4.  Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Leukemia       Date:  2021-09-03       Impact factor: 11.528

5.  Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

Authors:  Dan Liu; Zefeng Xu; Peihong Zhang; Tiejun Qin; Bing Li; Shiqiang Qu; Lijuan Pan; Wenyu Cai; Jinqin Liu; Huijun Wang; Qi Sun; Xiujuan Sun; Meng Jiao; Qingyan Gao; Zhongxun Shi; Huijun Huang; Gang Huang; Robert Peter Gale; Zhijian Xiao
Journal:  Blood Cancer J       Date:  2021-09-17       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.